Improvement of abnormal pyruvate metabolism and cardiac conduction defect with coenzyme Q10 in Kearns-Sayre syndrome.
In a patient with Kearns-Sayre syndrome, concentration of coenzyme Q10, a component of the mitochondrial electron transport system, was decreased in serum and in the mitochondrial fraction of skeletal muscle. Serum concentrations of lactate and pyruvate were abnormally high, especially after exercise or oral glucose loading. Levels of folic acid in plasma and CSF were decreased. ECG showed a first-degree atrioventricular block. After administration of coenzyme Q10 60 to 120 mg daily for 3 months, serum levels of lactate and pyruvate became normal, with improvement of atrioventricular block and ocular movements.
D000328:Adult; D003067:Coenzymes; D004562:Electrocardiography; D005215:Fasting; D006329:Heart Conduction System / Q000187:drug effects* / Q000503:physiopathology; D006801:Humans; D007625:Kearns-Sayre Syndrome / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism / Q000503:physiopathology; D007773:Lactates / Q000097:blood; D008297:Male; D009886:Ophthalmoplegia / Q000188:drug therapy*; D011773:Pyruvates / Q000097:blood / Q000378:metabolism*; D014451:Ubiquinone / Q000031:analogs & derivatives* / Q000097:blood / Q000627:therapeutic use
D003067:Coenzymes; D007773:Lactates; D011773:Pyruvates; D014451:Ubiquinone; C024989:coenzyme Q10